133 related articles for article (PubMed ID: 32162020)
21. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
[TBL] [Abstract][Full Text] [Related]
22. Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors.
Moon MH; Park HS; Kim YJ; Yu MH; Park S; Jung SI
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766584
[TBL] [Abstract][Full Text] [Related]
23. Deep learning for the ovarian lesion localization and discrimination between borderline and malignant ovarian tumors based on routine MR imaging.
Wang Y; Zhang H; Wang T; Yao L; Zhang G; Liu X; Yang G; Yuan L
Sci Rep; 2023 Feb; 13(1):2770. PubMed ID: 36797331
[TBL] [Abstract][Full Text] [Related]
24. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.
Li Y; Jian J; Pickhardt PJ; Ma F; Xia W; Li H; Zhang R; Zhao S; Cai S; Zhao X; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Lu J; Deng L; Wu X; Qiang J; Gao X
J Magn Reson Imaging; 2020 Sep; 52(3):897-904. PubMed ID: 32045064
[TBL] [Abstract][Full Text] [Related]
25. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components.
Timor-Tritsch IE; Foley CE; Brandon C; Yoon E; Ciaffarrano J; Monteagudo A; Mittal K; Boyd L
Ultrasound Obstet Gynecol; 2019 Sep; 54(3):395-402. PubMed ID: 30950132
[TBL] [Abstract][Full Text] [Related]
26. MRI for discriminating metastatic ovarian tumors from primary epithelial ovarian cancers.
Xu Y; Yang J; Zhang Z; Zhang G
J Ovarian Res; 2015 Aug; 8():61. PubMed ID: 26310488
[TBL] [Abstract][Full Text] [Related]
27. Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Qiang JW
Acta Radiol; 2021 Jan; 62(1):129-138. PubMed ID: 32276553
[TBL] [Abstract][Full Text] [Related]
28. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
29. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
30. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
Park SY; Oh YT; Jung DC
Acta Radiol; 2016 May; 57(5):633-9. PubMed ID: 26231948
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.
Yu XP; Liu Y; Jiao JW; Yang HJ; Wang RJ; Zhang S
Med Sci Monit; 2020 Aug; 26():e924497. PubMed ID: 32801292
[TBL] [Abstract][Full Text] [Related]
32. Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.
Ma FH; Li YA; Liu J; Li HM; Zhang GF; Qiang JW
J Magn Reson Imaging; 2019 Jun; 49(6):1684-1693. PubMed ID: 30353967
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound Features Improve Diagnostic Performance of Ovarian Cancer Predictors in Distinguishing Benign and Malignant Ovarian Tumors.
Chen YN; Ma F; Zhang YD; Chen L; Li CY; Gong SP
Curr Med Sci; 2020 Feb; 40(1):184-191. PubMed ID: 32166682
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
[TBL] [Abstract][Full Text] [Related]
38. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.
Mimura R; Kato F; Tha KK; Kudo K; Konno Y; Oyama-Manabe N; Kato T; Watari H; Sakuragi N; Shirato H
Jpn J Radiol; 2016 Mar; 34(3):229-37. PubMed ID: 26798066
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of Borderline Epithelial Ovarian Tumors from Benign and Malignant Epithelial Ovarian Tumors by MRI Scoring.
Babaoglu S; Atas AE; Kerimoglu U; Iyisoy MS; Kilinc F
Curr Med Imaging; 2024; 20():e060623217706. PubMed ID: 37282660
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.
Zacharakis D; Thomakos N; Biliatis I; Rodolakis A; Simou M; Daskalakis G; Bamias A; Antsaklis A
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):285-92. PubMed ID: 23193945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
